-
NICE sets out further details on menopause guideline update
NICE has outlined what aspects of menopause care will be updated in upcoming guidance, including areas where more research is needed.
-
New injectable immunotherapy treatment for rare form of triple negative breast cancer recommended by NICE
An estimated 100 people per year with triple negative breast cancer that has spread to other parts of the body may soon benefit from pembrolizumab in combination with chemotherapy (paclitaxel or nab-paclitaxel) following the final draft recommendation from NICE.
-
Thousands of people in England could benefit after NICE recommends treatment option for two forms of sight loss
NICE recommends faricimab as treatment option for adults with wet age-related macular degeneration or diabetic macular oedema
-
NICE recommends offering app-based treatment for people with insomnia instead of sleeping pills
Hundreds of thousands of people suffering from insomnia who would usually be prescribed sleeping pills could be offered an app-based treatment programme instead, NICE has said.
-
Draft NICE guidance recommends innovative technology used to establish whether breast cancer has spread
A magnetic marker liquid injected into people with invasive breast cancer will help surgeons discover if the cancer has spread, after the technology was recommended in draft NICE guidance.
-
More than 400 people could benefit from life-extending advanced lung cancer treatment after it was recommended for routine use on the NHS
Durvalumab recommended as an option for treating non-small-cell lung cancer (NSCLC)
-
Women with moderate to severe fibroids set to be offered new one-a-day treatment following final draft guidance from NICE
Around 4,500 women with uterine fibroids will be eligible for a new oral treatment after NICE recommended relugolix with estradiol and norethisterone acetate (also called Ryeqo and made by Gedeon Ritcher UK) in final draft guidance.
-
NICE outlines steps needed to put ME/CFS guideline into practice
NICE has today, International ME Awareness Day (Thursday, 12 May 2022) published its implementation statement which sets out the practical steps needed to put its recent guideline on the diagnosis and management of myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome (ME/CFS) into
-
Healthier lifestyle can help to ease osteoarthritis symptoms says NICE
Exercise has an important role to play in helping people living with osteoarthritis NICE says in draft updated guidelines published today (29th April 2022) on the care and management of people with the condition.